A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults
Clinical trial NCT05606965 · COMPLETED
Trial details
- NCT number
- NCT05606965
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-02
- Primary completion
- 2025-11-13
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.